Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Jump to

    • Concern is that established players like Sandoz, Teva are moving out: Lupin

    • USFDA warning: Lupin sees marginal impact on earnings; resolution to take 12-15 mths

    • Expect acquisitions to boost growth; several products lined up for next year: Lupin

    • Will unleash significant portion of product pipeline by 2020: Lupin

    • Lupin's growth in US to stay muted next year

    • Can grow at 18%; expect margins at 30% going ahead: Lupin

    • Not positive on Lupin's US business: Surajit Pal

    • Regulatory risks waning in pharma sector: IIFL

    • Lupin to see approvals after US FDA gives clean chit: Macquarie

    • In a relief to Lupin, US FDA closes 9 inspections made last year

    • Aspire to hit $5 bn in sales soon; focus on specialty biz: Lupin

    • Booster dose: Lupin unit gets US FDA clearance

    • Indian pharma cos need to step-up safeguards at plants: Handa

    • Cautious on Lupin as no clarity yet on USFDA action: Surajit Pal

    • Pharma cos capable of resolving FDA concern in 12-15 months:IIFL

    • Expect 26-28% op margin growth; eye more acquisitions: Lupin

    • US FDA approvals to see uptick from 2016: Lupin

    • Gavis arm Wintac not part of acquisition, says Lupin CFO

    • No material launch, price erosion impacted earnings: Lupin

    • Expect FY16 US generic launch for Nexium: Lupin

    • Always believe growth will come from acquisitions: Lupin

    • HDFC Bk can raise up to Rs 10k cr, Lupin to hike FDI limit

    • Yen depreciation to impact Japan business revenue: Lupin

    • Sun's margins may reduce to 30-32% post merger: Surajit Pal

    • Competition, seasonality led to weak Q2 results: Lupin

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347